GNE-900 - Moligand™, ≥98% , CAS No.1200126-26-6
Em stock
SKU
G648750
"}
GNE-900 is a an ATP-competitive and selective ChK1 inhibitor with IC50s of 0.0011, 1.5 μM for ChKl, ChK2, respectively. GNE-900 abrogates the G2-M checkpoint, enhances DNA damage, and induces Apoptosis. Gemcitabine (HY-17026) and GNE-900 administration shows anti-tumor activity
| CAS | 1200126-26-6 |
|---|---|
| Sinónimos | 3-(4-(Piperidin-1-ylmethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile |
| Especificações e pureza | Moligand™, ≥98% |
| Condições de armazenamento de armazenamento | Protected from light,Store at -20°C,Desiccated |
| Enviado em | Ice chest + Ice pads |
| Product Description | GNE-900 is a an ATP-competitive and selective ChK1 inhibitor with IC50s of 0.0011, 1.5 μM for ChKl, ChK2, respectively. GNE-900 abrogates the G2-M checkpoint, enhances DNA damage, and induces Apoptosis. Gemcitabine (HY-17026) and GNE-900 administration shows anti-tumor activity |
| Sensibilidade | Moisture sensitive |
| PubChem CID | 44545757 |